Nesiritide compared with milrinone for cardiac surgery

Annals of Pharmacotherapy

Volumn 41, Issue 3, 2007, Pages 502-504

  Blais, Danielle M ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cardiac surgery; Milrinone; Nesiritide

Indexed keywords

ALDOSTERONE; AMIODARONE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; DOBUTAMINE; DOPAMINE; ENDOTHELIN; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; VASODILATOR AGENT;

BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; FORWARD HEART FAILURE; HEART SURGERY; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SURGICAL MORTALITY; SURGICAL PATIENT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CARDIAC OUTPUT, LOW; HUMANS; MILRINONE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PHOSPHODIESTERASE INHIBITORS; RISK ASSESSMENT; THORACIC SURGERY;

EID: 34047215497     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H656     Document Type: Review

References (12)

1. Hannan EL, Raez MJ, Walford G, et al. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA 2003;290: 773-80.
2. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991;325:1468-75.
3. Felker GM, Benze RL, Chandler AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure. J Am Coll Cardiol 2003;41:997-1003.
4. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (β-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study. Am Heart J 2002;144:1102-8.
5. Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001;88:35-9.
6. Feneck RO. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. European Multicenter Trial Group. Am Heart J 1991;121:1995-9.
7. Feneck R, Sherry K, Withington S, et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001;15:306-15.
8. Abraham WT. Serum creatinine elevations in patients receiving nesiritide are related to starting dose (abstract 2789). Presented at: American Heart Association, Dallas, November 15, 2005.
9. Samuels LE, Holmes EC, Letwin L. Nesiritide as an adjunctive therapy in adult patients with heart failure undergoing high-risk cardiac surgery. J Thorac Cardiovasc Surg 2004;128:627-9.
10. Gordon GR, Schumann R, Rastegar H, et al. Nesiritide for treatment of perioperative low cardiac output syndromes in cardiac surgical patients: an initial experience. J Anesth 2006;20:307-11.
11. Hebeler RF. Effect of perioperative nesiritide administration on postoperative renal function and clinical outcomes in patients undergoing cardiothoracic surgery (abstract 292). Presented at: 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, DC, May 9, 2006.
12. Luber JM. Perioperative nesiritide use is associated with decreased 180-day mortality in heart failure patients undergoing cardiac surgery (abstract 235). Presented at: Heart Failure Society of America, Seattle, September 10, 2006.